Warner Bros. Discovery, Inc.
Pyridone-Pyrimidine Derivative Acting As KRASG12C Mutein Inhibitor
Last updated:
Abstract:
Provided are a class of KRAS G12C mutein inhibitors, which relate in particular to a compound represented by formula (I), an isomer thereof, and a pharmaceutically acceptable salt thereof. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
27 Jan 2021
Issue date:
20 May 2021